Fig. 2
From: Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases
Structures of compounds with therapeutic effects in C. elegans models of human neurodegenerative diseases. Chemical structures were obtained from PubChem (https://pubchem.ncbi.nlm.nih.gov) or MolBase (http://www.molbase.com). AD Alzheimer’s disease, ALS amyotrophic lateral sclerosis, ANCL adult-onset neuronal ceroid lipofuscinosis, FTDP frontotemporal dementia with parkinsonism-17, HD Huntington’s disease, MJD Machado–Joseph disease (spinocerebellar ataxia type 3), PD Parkinson’s disease, Prion prion disease, SMA spinal muscular atrophy